Multi-phased kinetics and interaction of protein kinase signaling in glycoprotein VI-induced platelet αIIbβ3 integrin activation and degranulation

Pengyu Zhang,Saskia von Ungern-Sternberg,Luisa Hastenplug,Fiorella Solari,Albert Sickmann,Marijke Kuijpers,Johan WM Heemskerk,Ulrich Walter,Kerstin Jurk
DOI: https://doi.org/10.1055/a-2311-0117
2024-04-23
Thrombosis and Haemostasis
Abstract:Background: Platelet glycoprotein VI (GPVI) stimulation activates the tyrosine kinases Syk and Btk, and the effector proteins phospholipase Cγ 2 (PLCγ2) and protein kinase C (PKC). Here, the activation sequence, crosstalk and downstream effects of this Syk-Btk-PKC signalosome in human platelets was analyzed. Methods and Results: Using immunoblotting, we quantified 14 regulated phospho-sites in platelets stimulated by convulxin with and without inhibition of Syk, Btk or PKC. Convulxin induced fast, reversible tyrosine phosphorylation (pY) of Syk, Btk, LAT and PLCγ2, followed by reversible serine/threonine phosphorylation (pS/T) of Syk, Btk and downstream kinases MEK1/2, Erk1/2, p38 and Akt. Syk inhibition by PRT-060318 abolished all phosphorylations, except Syk pY352. Btk inhibition by acalabrutinib strongly decreased Btk pY223/pS180, Syk pS297, PLCγ2 pY759/Y1217, MEK1/2 pS217/221, Erk1/2 pT202/Y204, p38 pT180/Y182 and Akt pT308/S473. PKC inhibition by GF109203X abolished most pS/T phosphorylations except p38 pT180/Y182 and Akt pT308, but enhanced most Y-phosphorylations. Acalabrutinib,but not GF109203X, suppressed convulxin-induced intracellular Ca2+ mobilization, whereas all three protein kinase inhibitors abolished degranulation and αIIbβ3 integrin activation assessed by flow cytometry. Inhibition of autocrine ADP effects by AR-C669931 partly diminished convulxin-triggered degranulation. Conclusion: Kinetic analysis of GPVI-initiated multisite protein phosphorylation in human platelets demonstrates multiple phases and interactions of tyrosine and serine/threonine kinases with activation-altering feedforward and feedback loops partly involving PKC. The protein kinase inhibitor effects on multisite protein phosphorylation and functional readouts reveal that the signaling network of Syk, Btk and PKC controls platelet granule exocytosis and αIIbβ3 integrin activation.
peripheral vascular disease,hematology
What problem does this paper attempt to address?
The paper primarily explores the series of signal transduction processes following the activation of the platelet membrane protein hexamer (GPVI) receptor, particularly the mechanisms of action of downstream effector molecules such as tyrosine kinases Syk and Btk, as well as mitogen-activated protein kinases (MAPKs) and Akt in platelet activation. Specifically, the study addresses the following key issues: 1. **Sequence and Interaction of Signal Transduction**: Using immunoblotting techniques, the study quantified changes in 14 regulatory phosphorylation sites at different time points after GPVI receptor activation, revealing the activation sequence and interactions between tyrosine kinases Syk, Btk, and mitogen-activated protein kinases (including PLCγ2, MEK1/2, Erk1/2, p38, and Akt) and their effects on platelet function. 2. **Dynamics of Tyrosine and Serine/Threonine Phosphorylation**: The study found that GPVI stimulation leads to rapid and reversible tyrosine phosphorylation, followed by serine/threonine phosphorylation, indicating a complex interaction between tyrosine and serine/threonine kinases. 3. **Role of Inhibitors**: Various inhibitors (such as the Syk inhibitor PRT-060318, the Btk inhibitor acalabrutinib, and the PKC inhibitor GF109203X) were used to explore the specific roles of these kinases in the signaling network and to analyze their effects on platelet functions (such as granule secretion and αIIbβ3 integrin activation). 4. **Functional Impact**: The effects of the inhibitors further validated the functional roles of the Syk, Btk, and PKC signaling networks in controlling platelet granule secretion and αIIbβ3 integrin activation. In summary, the study reveals the complex interactions between tyrosine kinases and serine/threonine kinases and their specific effects on platelet function by deeply analyzing the dynamic changes in multi-stage protein phosphorylation during GPVI-mediated platelet activation.